The rare disease diagnostic odyssey lasts on average 4.5 years. But what would happen if a novel innovation could diagnose a person with a rare disease instantaneously? Vanessa Lemarié, Director of Life Sciences Business Development and Program Owner of the Rare Disease Initiative at Ada Health, explains how the company is leveraging their ground-breaking medical AI technology to simplify diagnostic pathways and make the rare disease diagnostic odyssey a thing of the past.